SABBY MANAGEMENT LLC 13D and 13G filings for InMed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-03 4:17 pm Purchase |
2024-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
SABBY MANAGEMENT LLC | 36,135 4.900% |
34,823 (+2653.29%) |
Filing |
| 2024-01-03 5:43 pm Purchase |
2023-12-31 | 13G | InMed Pharmaceuticals Inc. INM |
SABBY MANAGEMENT LLC | 1,312 11.000% |
1,312 (New Position) |
Filing |